Maurits Geerlings

Company: NanoCell Therapeutics

Job title: Co-Founder, President & Chief Executive Officer

Seminars:

Reimagining CAR & Protein Manufacturing Processes to Revolutionize Treatment Payload Manufacturing 1:00 pm

Modifying the CAR manufacturing process to overcome manufacturing challenges caused by the hydrophobic domain of CARs Understanding the complexities of protein multidomain to enhance and simplify the protein purification process during manufacturing Exploring cargo expression suppression in lentiviral manufacturing to maximize efficient production and prevent interference in particle production Read more

day: Day Two

Panel Discussion: ‘Evaluating LVV & LNP Delivery Method Clinical Potential in In Vivo Cell & Gene Therapies 2:00 pm

Discussing the long-term efficacy and durability of LVV and LNP-based therapies to understand the impact of delivery on disease regression and treatment Exploring how LVV, LNP and RNP technologies can evolve to produce enhanced therapeutic outcomes Evaluating the potential of the delivery vehicles to deliver complex payloadsRead more

day: Day Two